A. H. Azam

This study identifies two viral strategies to evade bacterial retrons: supplying tRNATyr to counteract retron 78 and using Rad to degrade retron noncoding RNA precursors.

This study shows that selecting specific bacteriophages in combination with antibiotics can reduce the emergence of resistant bacteria, using Escherichia coli O157:H7 as a model.

This study identifies IMPDH as a potential target for anti-monkeypox virus agents by showing that compounds targeting this enzyme inhibit MPXV replication more effectively than existing treatments.

This study identifies atovaquone, mefloquine, and molnupiravir as potential anti-monkeypox virus drugs, with atovaquone showing enhanced efficacy when combined with tecovirimat.

This study develops CRISPR-Cas13a-based antimicrobials that kill target bacteria by cleaving RNA, showing effectiveness against carbapenem-resistant E. coli and methicillin-resistant S. aureus.

The paper analyzes CRISPR-Cas13a and other CRISPR-Cas systems in 11 Leptotrichia strains, revealing their diversity, distribution, and evolutionary relationships.

This study identifies a novel host-recognition mechanism in the kayvirus phiSA039 that allows it to infect both Staphylococcus aureus and S. pseudintermedius by adapting its receptor and exploiting differences in WTA glycosylation.

This study identifies mutations in Staphylococcus aureus SA003 conferring resistance to phage phiSA012 and shows that phiSA039 uses a different binding mechanism involving beta-GlcNAc in Wall Teichoic Acid.